Tiny study suggests upadacitinib may work for Hard-to-Treat small bowel Crohn's
NCT ID NCT07597577
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study looked at how well the drug upadacitinib works for Crohn's disease when it only affects the small bowel, compared to when it affects other parts of the digestive tract. Researchers reviewed records of 3 people with active Crohn's who took upadacitinib for 12 weeks. They used ultrasound to measure bowel inflammation and checked symptoms and lab results to see if the drug was effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangdong, Guangzhou, 510000, China
Conditions
Explore the condition pages connected to this study.